Patent · US Expired

1-2-(2,3-Dihydro-1H-inden-1-yl)ethyl!-4-(naphthalen-1-yl) piperazine, derivatives, preparation thereof and therapeutical use thereof

US5929078A · kind A · utility

1Cited by
4References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 1998
Grant dateJul 27, 1999
Priority date
Expiry dateFeb 3, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/096
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds corresponding to the general formula (I): ##STR1## in which X represents a hydrogen atom, a hydroxyl group, a C.sub.1 -C.sub.3 alkoxy group or a cyclopropylmethoxy group and Y represents a hydrogen atom, a hydroxyl group or a methoxy group and salts and bases thereof. The compounds may exists in the form of a pure enantiomer or as a mixture of enantiomers. Additionally, the compounds of formula (I) are useful for the treatment of diseases associated with serotoninergic receptors, particularly anxiety and/or depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.